Investigational Immunotherapy for Advanced Melanoma Shows Early Promise in Phase 1 Trial
News
Patients with advanced melanoma may benefit from an investigational new immunotherapy called IMC-20D7S, according to data from a first-in-human Phase 1 clinical trial. The study, “An Open-Label, Dose-Escalation Phase I ... Read more